Key facts
- Proxima Health’s last known valuation is $25.0M (Apr 2025).
- It has raised $6.9M; the latest was Seed Round ($6.9M) in Apr 2025.
- Notable investors include FundersClub, Long Journey Ventures, Xtal Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Proxima Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Proxima Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Proxima Health
Operator of a biotechnology company intended to prevent chronic disease and optimize health through the early detection and removal of environmental toxins. The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- Austin, TX, United States
- Founded
- 2024
- Employees
- 2
- Website
- proxima.health/
- Ownership
- Privately Held (backing)
Proxima Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Proxima Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Proxima Health in its N-PORT filings yet. We sweep new filings monthly.